By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

42
By Dr. Olga Korosteleva Today’s Talk: Surviving Survival Analysis By Kelley Mizukami

Transcript of By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

Page 1: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

By Dr. Olga Korosteleva

Today’s Talk:

Surviving Survival AnalysisBy Kelley Mizukami

Page 2: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

OUTLINE

• What is Survival Analysis?• Censored Data• Kaplan-Meier Estimator• Log-Rank Test• Cox Regression Model

Page 3: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

WHAT IS SURVIVAL ANALYSIS?

• Branch of statistics that focuses on time-to-event data and their analysis.

• Survival data deal with time until occurrence of any well-defined event.

• The outcome variable examined is the survival time (the time until the occurrence of the event).

• Special because it can incorporate information about censored data into analysis.

Page 4: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

OBJECTIVES OF SURVIVAL ANALYSIS?

• Estimate probability that an individual surpasses some time-to-event for a group of individuals.– Ex) probability of surviving longer than two months until

second heart attach for a group of MI patients.• Compare time-to-event between two or more

groups.– Ex) Treatment vs placebo patients for a randomized

controlled trial.• Assess the relationship of covariates to time-to-

event.– Ex) Does weight, BP, sugar, height influence the survival

time for a group of patients?

Page 5: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

SITUATIONS WHEN WE CAN USE SURVIVAL ANALYSIS

• We can use survival analysis when you wish to analyze survival times or “time-to-event” times

• “Time-to-Event” include:– Time to death– Time until response to a treatment– Time until relapse of a disease– Time until cancellation of service– Time until resumption of smoking by someone

who had quit– Time until certain percentage of weight loss

Page 6: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

MORE EXAMPLES• Suppose you wish to analyze the time it takes for a

student to complete a series of classes. – Response /Status Variable: Time it takes to complete,

status– Predictor Variables: Age, Gender, Race, GPA

• Suppose you wish to analyze the time between admittance to the hospital until death for a lung cancer patient. – Response/Status Variables : Length-of-Follow up, status– Predictor Variables: Age, Gender, Race, White Blood

Counts, Tumor Type, Treatment Type, Cancerous Mass Size

Page 7: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

MORE EXAMPLES• Suppose you are interested in comparing the time

until you lose 10% body weight on one of two exercise programs. – Response/Status Variables: Time it Takes, Status– Predictor Variables: Age, Gender, Starting Weight, BP,

BMI, Exercise Program

• Suppose you are interested in the time it takes before one sees results for a certain treatment.– Response/Status Variables: Time it Takes, Status– Predictor Variables: Age, Gender, Type of Treatment,

Weight, Height, exercise (Y/N), healthy eating (Y/N)

Page 8: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

MORE EXAMPLES• Suppose you wish to compare the time it takes

before you cancel your cable TV service when you use two different cable providers.– Response/Status Variables: Time it Takes, Status– Predictor Variables: Age, Gender, Race, Cable Provider,

Average Income, Average number of complaints per month

Page 9: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

DATA• Survival data can be one of two types:

– Complete Data– Censored Data

• Complete data – the value of each sample unit is observed or known.

• Censored data – the time to the event of interest may not be observed or the exact time is not known.

• We distinguish complete data from censored data by adding a “+” to any values that are censored. (i.e. 4+)

Page 10: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

CENSORED DATA• Censored data can occur when:

– The event of interest is death, but the patient is still alive at the time of analysis.

– The individual was lost to follow-up without having the event of interest.

– The event of interest is death by cancer but the patient died of an unrelated cause, such as a car accident.

– The patient is dropped from the study without having experienced the event of interest due to a protocol violation.

• Even if an observation is censored we will still include it in our analysis.

Page 11: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.
Page 12: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

FUNCTION DESCRIBING SURVIVAL TIMES

• is a random variable that represents survival time.

• The distribution of survival time can be described by the survival function.

Page 13: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

SURVIVAL FUNCTION

• Let T denote the survival time, a random variable with the survival function:

Probability that a subject selected at random survives longer than time t.• Properties

– is bounded by 0 and 1, it is a probability– is a non-increasing function

Page 14: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

SURVIVAL FUNCTION

• If there is no censoring, then a good estimator of , at time , is:

But usually there is censoring. Therefore we can estimate using the Kaplan-Meier estimator.

Page 15: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

KAPLAN-MEIER ESTIMATOR

Page 16: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

KAPLAN-MEIER (KM) ESTIMATOR

• Helps us find when there are censored data. • To find this KM estimator break up survival

probability into a sequence of conditions.• The probability of surviving or more years

from the beginning of the study is a product of observed survival rates.

Page 17: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

KAPLAN-MEIER ESTIMATOR

: estimated by the proportion of people living through out of those who have survived beyond

: number at risk at : number who died at

- = number who survived beyond

Page 18: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

HOW TO CALCULATE THE KM ESTIMATOR

EVENT TIMES (n=12): 2 3+ 5 6 7+ 10 15+ 16 16 27 30 32RECALL:

• Skip censoring points since they don’t change until we get to the next time point.

Page 19: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

SURVIVAL CURVE

Page 20: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

EXAMPLE DATA• The MYEL Data Set: Myelomatosis Patients

• The MYEL data set contains survival times for 25 patients diagnosed with myelomatosis (Peto et al., 1977). The patients were randomly assigned to two drug treatments. The variables are as follows:

• DUR is the time in days from the point of randomization to either death or censoring

• STATUS has a value of 1 if dead and a value of 0 if alive. » This tells is that the censored value will be 0 if the patient is alive and

1 or uncensored if they are dead

• TREAT specifies a value of 1 or 2 that corresponds to the two treatments.

• RENAL has a value of 1 if renal functioning was normal

Page 21: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

WHAT DO THE DATA LOOK LIKE?

• Snapshot of the datadur status treat renal

8 1 1 1180 1 2 0632 1 2 0852 0 1 052 1 1 1

2240 0 2 0220 1 1 063 1 1 1

195 1 2 076 1 2 070 1 2 08 1 1 0

Page 22: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

KM EXAMPLE USING SPSS

• Analyze > Survival > Kaplan Meier

• Time: Dur• Status: status(1)

– Here define 1 since it the value indicating event has occurred (i.e. death)

• Options: Check off survival plot

Page 23: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

OUTPUT

Page 24: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

OUTPUT

Page 25: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

OUTPUT

Page 26: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

LOG-RANK TEST

Comparing the survival curves of two treatment groups

Page 27: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

LOG-RANK TEST

• Use the Log-Rank Test to compare the survival functions of two samples.

• H0: The two survival functions are the equivalent

• Ha: The two survival functions are different

Page 28: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

TEST STATISTIC

• Test statistic:

• : Total observed deaths from group A• : Total expected deaths from group A

Page 29: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

EXAMPLE USING SPSS

• Analyze > Survival > Kaplan Meier

• Time: dur• Status: status(1)

– Here define 1 since it the value indicating event has occurred (i.e. death).

• Factor: Treat• Options: Check off survival plot• Click on “Compare Factor” and choose “Log-Rank”

Page 30: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

OUTPUT

Page 31: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

OUTPUT

Page 32: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

OUTPUT

Page 33: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

COX REGRESSION MODEL

Incorporating Covariates

Page 34: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

SURVIVAL MODELS

• Models that relate the time that passes before some event occurs to one or more covariates that may be associated with that amount of time.

Page 35: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

COX REGRESSION MODEL

• This model produces a survival function that predicts the probability that an event has occurred at a given time t, for given predictor variables (covariates).

Page 36: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

COX REGRESSION MODEL

• is the time• are the covariates for the individual• is the baseline hazard function. This is the

function when all the covariates equal to zero.

Page 37: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

HAZARD FUNCTION

• The hazard function:

This is the risk of failure immediately after time given they have survived past time t.

Page 38: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

INTERPRETATION OF THE BETAS

• First we need to find the ratio when there is a one unit increase in the covariate, provided the other covariates stay fixed.

• We interpret as the increase in log hazard per unit of

Page 39: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

EXAMPLE USING SPSS• Analyze > Survival > Cox Regression• SPSS fits the model with minus beta

coefficients: It has to be taken into account when interpreting the coefficients

• Time: Dur• Status: status(1)

– Censoring value: 1• Covariates: treat, renal

– Categorical: treat, renal

Page 40: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

OUTPUT

Page 41: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

OUTPUT

Interpretation:• The hazard for patients receiving treatment 2

is 28.8% of that for treatment 1 patients. • Patients with normal renal function have 1.6%

hazard as compared to those whose renal function is abnormal.

Page 42: By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

42